超越西利宾:其他西利马林黄素的重要性
Michal Selc1,2, Andrea Babelova1,2
1Centre for Advanced Material Application, Slovak Academy of Sciences, Bratislava, Slovakia.
Frontiers in pharmacology
|August 5, 2025
概括
来自乳的西利玛林,除了其主要成分西利宾之外,还提供了潜在的潜力. 探索其他黄素素可能会揭示药物发现的新疗法应用.
科学领域:
- 植物化学 植物化学
- 药理学 药理学是指药理学的学科.
- 自然产品 药物发现 药物发现
背景情况:
- 乳提取物西利马林 (Silymarin) 已被认为具有保护肝脏的作用.
- 研究主要集中在西利宾上,忽视了其他活性黄素.
- 未充分研究的成分可能具有显著的治疗潜力.
研究的目的:
- 突出研究不足的西利马林成分的药理潜力.
- 为了探索超越silybin.新的治疗机会.
- 推进基于黄的药物开发.
主要方法:
- 关于西利玛林成分的文献综述.
- 对鲜为人知的黄素的药理活性进行分析.
- 对治疗潜力的比较评估.
主要成果:
- 西利马林含有多种类型的黄素 (例如,西利克里斯,异酸,西利迪安,脱水酸,出租车).
- 这些成分表现出强大的抗氧化,抗炎,抗病毒和抗癌活性.
- 与silybin.com相比,具有独特或优越药理学效果的潜力.
结论:
- 缺乏研究的西利马林成分需要进一步调查.
- 这些化合物为新药发现提供了有前途的途径.
- 可以开发个性化的植物疗法和下一代治疗方法.
更多相关视频
14:39Semi-Targeted Ultra-High-Performance Chromatography Coupled to Mass Spectrometry Analysis of Phenolic Metabolites in Plasma of Elderly Adults
Published on: April 22, 2022
4.0K
09:03Establishment of Hepatocarcinoma in BALB/c-nu Mice and Investigation of the Therapeutic Effect of the Sanleng Jiashen Formula
Published on: January 26, 2024
464
相关概念视频
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K
Bioavailability: Overview
3.1K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
3.1K
Factors Affecting Drug Biotransformation: Biological
241
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
241
Factors Influencing Bioavailability: First-Pass Elimination
7.0K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
7.0K
